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Background: Vitamin B12 is a fascinating molecule which acts as a co-factor in the metabolism of many organisms,
especially affecting DNA synthesis and regulation, fatty acid synthesis and energy production. The synthesis of
vitamin B12 is limited to a few of bacteria and archaea. Therefore, industrial microbial fermentation is used to meet
annual demands worldwide of vitamin B12 and as an alternative method to the chemical synthesis which requires
at least 60 steps that is uneconomical. Bacillus megaterium is one of vitamin B12 producers and an ideal host for
many biotechnology applications and being one of the best tools for the industrial production of several enzymes.
Therefore, a two-step optimization strategy was established to produce high yield of vitamin B12 by B. megaterium
through the provision of the production requirements and the suitable conditions for the biosynthesis of vitamin B12.
Results: We achieved the optimum conditions for the fermentation process of B. megaterium to produce high yield of
vitamin B12 in a practical way based on statistical design and analysis which allowed vitamin B12 production to
increase up to 759-fold (204.46 μg/l) as compared with control without parameters (0.26 μg/L). High performance liquid
chromatography coupled to variable wavelength detector and mass spectrometry has been used to identify vitamin
B12 forms and confirm the results.
Conclusions: We developed the fermentation process of B. megaterium to enhance the production of vitamin B12
by providing the required supplements for the synthesis of vitamin B12 (CoCl2, δ-aminolevulinic acid (ALA) and
5,6-dimethylbenzimidazole (DMB)) and dividing the fermentation process into three stages. In addition, the
optimum incubation times of the three fermentation stages were investigated and performed with reducing
number of experimental and evaluated multiple parameters and their interactions by using statistical experimental
design and analysis. All of these strategies has proven successful in enhancing the production of vitamin B12 up to
204.46 μg/l and demonstrated that B. megaterium could be a good candidate for the industrial production of vitamin B12.
Keywords: Vitamin B12, Bacillus megaterium, δ-Aminolevulinate (ALA), 5, 6-dimethylbenzimidazole (DMB)Background
Vitamin B12 is one of the smallest but structurally complex
molecule widely recognized in the field of biological sci-
ences [1]. It is a water-soluble vitamin that functions as
a cofactor essential in fat biochemical reactions, protein
metabolism and hemoglobin synthesis as well as DNA
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article, unless otherwise stated.coenzyme forms; methylcobalamin and adenosylcobala-
min [2,3]. However, vitamin B12 commercially known
as cyanocobalamin is a product formed by substituting
adenosyl and methyl with a cyano group during the ex-
traction process to ensure stability [4]. Industrial micro-
bial fermentation is used as an alternative method to the
originally established vitamin B12 chemical synthesis
which requires at least 60 steps [5]. The natural process
of vitamin B12 is synthesis by approximately 30 enzyme-
mediated steps proceeding either through aerobically
evident in Pseudomonas denitrificans, or anaerobically as wit-
nessed in Bacillus megaterium, Propionibacterium shermanii,
Salmonella typhimurium and Lactobacillus reuteri [6-8].ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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of the first established vitamin B12 producers [8] and
has recently been embraced as a perfect model for anaer-
obic vitamin B12 biosynthesis thereby aiding in under-
standing the control and regulation of the cobalamin
pathway as well as a biochemistry insight of the pathway
[9]. Furthermore B. megaterium is a GRAS organism and
the other features that make this strain an ideal host for
the genetic modification and industrial production of vita-
min B12 [10,11].
Several studies have extensively assessed the genetic
and biochemical aspects regarding vitamin B12 produc-
tion pathway in B. megaterium. Moreover, attempts have
been carried out in other study to engineer the bacteria
using metabolic engineering tools [12] but the final con-
centration of vitamin B12 was not high (8 μg/l) probably
due to the lack of understanding due to the lack of un-
derstanding the pathway of vitamin B12 and production
conditions of B. megaterium on vitamin B12.
Establishing the production requirements and under-
standing of the entire vitamin B12 pathway are vital in
optimizing the fermentation process to increase the prod-
uctivity. Although known as a strict aerobe, B. megaterium
can produce vitamin B12 under a very low oxygen con-
centrations through a complex pathway that involves at
least 25 conversion steps from δ-aminolevulinate (ALA)
to 5, 6-dimethylbenzimidazole (DMB) but it still requires
oxygen to allow for the completion of the formation of
vitamin [13,14].
The aim of this research was to optimize the fermenta-
tion process of B. megaterium using two-step optimization
strategies to produce high yields of vitamin B12. In the
first strategy, the fermentation process was modified by
dividing into three stages. At the first stage, the bacteria
was grown aerobically to increase the biomass, followed
by anaerobic growth stage for production vitamin B12
precursor and in the third stage, whole culture aeration
step was used to complete vitamin B12 formation. In
addition, the significance of CoCl2, ALA and DMB as sup-
plements have been investigated. In the second strategy,
the optimum time for each stage in the three stages of fer-
mentation process was investigated and optimized using
Box-Behnken design combined with Response surface
methodology (RSM) to investigate the most suitable time
for each stage in order to achieve high yield of vitamin
B12. To our knowledge this is the first report that ad-




A two-step optimization strategy was employed to in-
crease the production of vitamin B12 by Bacillus megater-
ium through the provision of the required supplementsfor the synthesis of vitamin B12 (CoCl2, δ-aminolevulinic
acid (ALA) and 5,6-dimethylbenzimidazole (DMB)) and
the division of the fermentation process into three stages.
In addition, the incubation times of the three fermentation
stages were investigated and optimized in a practical way
based on statistical design and analysis. All the measure-
ments were done using High performance liquid chroma-
tography and mass spectrometry to estimate vitamin B12
quantitatively and qualitatively.
Confirmation of vitamin B12 analysis
In nature, there are many of vitamin B12 analogues and
some of them are not active for human and have no any
economic value, especially for B. megaterium as one of
the anaerobic vitamin B12 producers reveals pseudovita-
min B12 (inactive form of vitamin B12) [9,15]. Therefore,
there was a need to use HPLC and MS analysis to confirm
the active forms of vitamin B12 (cyanocobalamin & adeno-
sylcobalamin) unlike unreliable analysis methods such as
cobalamin bioassay which is not accurate and measures all
of the vitamin b12 analogues without distinction, including
the inactive form of vitamin B12.
During the analyzing process, UV–vis spectra data and
retention times obtained by HPLC analysis showed that
B. megaterium produces two major forms of vitamin
B12 cyanocobalamin and adenosylcobalamin due to the
transformation efficiency of the cell extraction (to re-
place the adenosyl and methyl group to cyano group)
but the yield was not high enough. By contrary, the
transformation efficiency of Propionibacterium freudenrei-
chii cell extraction was high in our separate experiments
(data not shown). Therefore, the total concentration of
vitamin B12 was used as response.
The cell-extracts of B. megaterium revealed a peak with
a retention time of 15.10 min which is agreed with the
cyanocobalamin standard (15.10 min) as shown in Figure 1.
The cell extraction also showed a peak with a retention
time 17.007 min (Figure 2A), that is in agreement with the
adenosylcobalamin standard (17.093 min) in Figure 2B.
The mass spectrometry data (Figure 3) showed that the
mass spectra of the isolated compounds produced by B.
megaterium are 1355.56 and 1579.71 that are very similar
values of vitamin B12 analogues standard cyanocobalamin
and adenosylcobalamin 1355.55 and 1579.65, respectively.
Consequently, these data showed the HPLC reliability and
support the results. All of the data thus demonstrated the
ability of B. megaterium to produce adenosylcobalamin
which was transformed some to cyanocobalamin during
the extraction process.
The first step of optimization
In this part of the experiment, we evaluated the influence
of CoCl2, ALA and DMB as supplements on vitamin B12
production by B. megaterium. In addition, we divided the
Figure 1 HPLC chromatogram of cell extraction of B.
megaterium for sample (A) and standard cyanocobalamin (B).
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proven successful. As shown in Figure 4, more than 170-
fold increase of vitamin B12 was achieved by wild type of
B. megaterium (44.38 μg/l), as compared with control
without the parameter studies (0.26 μg/l) in this study and
others [16]. Two major forms of vitamin B12, cyano-
cobalamin and adenosylcobalamin were present in the cell
extraction of B. megaterium confirmed by UV spectra and
MS data.
The starting point of this step was to optimize the first
part of vitamin B12 pathway (uroporphyrinogen III syn-
thase) and consequently increase the final product (vitamin
B12). δ-aminolevulinic acid (ALA) is the key precursor
of uroporphyrinogen III biosynthesis and at the begin-
ning of vitamin B12 pathway [7,9]. Many studies have
been focused on increasing the productivity of ALA by
the overexpression of some genes (hemA, hemL) in order
to enhance the production of vitamin B12 [16,17]. In our
study, we added ALA (100 mg/l) directly into the culture
medium and this led to more than 21-fold (5.66 μg/L) im-
provements in vitamin B12 (Figure 4). Although a large
part of ALA flowed towards hemE along the branched
pathway, several attempts were made to reduce the flow
towards this pathway and also to reduce the possibility of
harmful high hemE concentrations [16].
Regarding the final part of vitamin B12 pathway
(adenosylcobinamide bioconversion), it is not com-
pletely elucidated. It required for the conversion ofadenosylcobinamide to adenosylcobalamin (vitamin
B12) through the replacement of the GDP group of
adenosyl-GDP-cobinamide with α-ribazole which con-
sists of the 5, 6-dimethylbenzimidazole (DMB) attached
to ribose [18]. B. megaterium has proven to produce an
inactive vitamin B12 (pseudovitamin-B12) instead of vita-
min B12 like most of the anaerobic producers of vitamin
B 12 [9,15] due to the failure to provide the suitable con-
ditions for the synthesis of DMB to complete the forma-
tion of vitamin B12. In our studies two strategies were
used to optimize the last part of the anaerobic biosyn-
thesis of vitamin B12 (adenosylcobinamide bioconver-
sion) by adding DMB (100 mg/l) at aerobic incubation in
the last phase of the fermentation that resulted more than
8-fold increase in the production of vitamin B12
(2.217 μg/L) as indicate in Figure 4.
Finally, the fermentation process of B. megaterium was
divided into three stages. At the first stage, the cells were
grown aerobically to increase the biomass and in the
second stage, the bacteria were grown anaerobically to
produce vitamin B12 precursor. Subsequently, vitamin
B12 formation was completed by aeration of the whole
culture. Taking into account, the vitamin B12 precursors
ALA and DMB were added into the fermentation medium.
As shown in Figure 4 the concentration of vitamin B12
was significantly increased up to 44.38 μg/l. Therefore,
this factor was considered in the next step of our study.
The second step of optimization
The experimental runs for the Box–Behnken design are
shown in Table 1. The 17 runs were used to address the
effects of three factors (incubation time for three stages
of the fermentation process) on three responses (biomass,
total concentration of vitamin B12, amount of vitamin
B12 produced per g dry cells) as shown in Additional file 1.
According to the results, the second step of the
optimization led to fruitful results. In addition, the ANOVA
analysis for all of the responses indicated that the models
used to fit the responses variables were significant (p <0.05)
and adequate to represent the relationship between the re-
sponses and the independent variables. Moreover, the co-
efficients of determination (R2) of the results were more
than 90%, which indicated that the results adequately rep-
resented the real relationship between the variables under
consideration as shown in Additional files 2, 3, 4 and 5.
For the biomass, the optimal bacterial biomass was
15.8 gram dry cell weight per liter culture as shown in
Figure 5 and it was obtained from sample number 10
under incubation time 9 h for the first stage of the fer-
mentation, 24 h for the second stage and 6 h for the
final stage. It was clear that the highest biomass yield
could be achieved by shortening the incubation time for
the first and third fermentation stages when the second
period of the fermentation was constant at 24 h.
Figure 2 HPLC chromatogram of cell extraction of B. megaterium for sample (A) and standard adenosylcobalamin (B).
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optimal conditions for the total vitamin B12 concentra-
tion. It has been noticed that the anaerobic condition
has no substantial effects on the biomass even without
the first aerobic stage. In this case, the logarithmic
growth phase of the bacteria has lasted during all the
second stage of the fermentation until the third stage.
Moreover, we could overcome this issue by increasing
the amount of the inoculation of the bacteria at the be-
ginning of the fermentation process.
In the cases of the total vitamin B12, Figure 6 indicates
that the highest concentration of the total vitamin B12
per liter was achieved in sample number 3 by reducing
the incubation time for the first stage to 0 h with in-
creasing the incubation time for the second stage up to
24 h during all levels of the third stage especially at
12 h. In contrast, the increasing the incubation time for
the first stage with reducing the period of the second
stage led to a significant reduction in the yield of vita-
min B12 as shown in Figure 6 in the sample number 8
and 11.
In relation to the final response, vitamin B12 concen-
trations per g DCW, the highest concentration was insample number 3 as shown in Figure 7. A remarkable in-
crease in the concentration of vitamin B12 per g DCW
was achieved by reducing the incubation time for the
first stage and increasing the time of the second stage
with incubation time approximately 12 h in third stage.
While the lowest concentration of vitamin B12 per g
DCW was in sample number 11 due to the increase of
the incubation time for the first stage and the decrease
of the incubation time for the second stage.
Both of the total vitamin B12 and the concentration of
vitamin B12/g DCW have shown significant agreement
and compatibility. The optimal yield of vitamin B12
observed in 17 runs of the experimental design was
204.456 μg/l and 15.3342 μg/g DCW during 24 h for the
second stage and 12 h for the third stage without the
first stage fermentation. In general, a significant increase
in the productivity was achieved when the first stage was
canceled or reduced, accompanied by the increased time
of the second stage up to 24 h using 6–12 h for the third
stage. This is due to the fact that the synthesis of the
precursors or intermediary metabolites of vitamin B 12
in the cells requires anaerobic conditions during the
logarithmic phase of growth and that was provided by
Figure 3 Mass spectrometry spectrum of the corrinoids purified from B. megaterium.
Figure 4 Total vitamin B12 content from B.megaterium under different conditions. All the measurements were done in triplicates with
error margins of 10%.
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1 8 18 15 18
2 14 9 15 12
3 15 9 15 12
4 1 0 6 12
5 6 18 15 6
6 11 9 6 18
7 3 0 24 12
8 5 0 15 6
9 17 9 15 12
10 13 9 15 12
11 12 9 24 18
12 10 9 24 6
13 4 18 24 12
14 9 9 6 6
15 7 0 15 18
16 16 9 15 12
17 2 18 6 12
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the beginning of the fermentation without resorting to use
the first stage (aerobic conditions). During the optimum
time for the third stage (12 h), the biomass was signifi-
cantly increased along with the completion of vitaminFigure 5 Biomass from the second step of optimization under differe
B. megaterium. All the measurements were analyzed by ANOVA analysis
Adeq Precision =11.310.B12 formation at the end of the logarithmic phase and
throughout the stationary phase during the third stage
of the fermentation process.
Although many studies investigated the anaerobic bio-
synthesis of vitamin B12 in B. megaterium in terms of gen-
etics and biochemical characterization [9,19], optimization
studies of the fermentation process have not been studied.
In this study, we successfully developed new strategies for
the fermentation process of B. megaterium to enhance the
production of vitamin B12 through the sequential fermen-
tation methods. Two major forms of vitamin B12, cyano-
cobalamin and adenosylcobalamin were present in the cell
extraction of B. megaterium confirmed by UV spectra and
MS data. More than 750-fold increase of vitamin B12 was
achieved by wild type of B. megaterium (204.46 μg/l), as
compared without parameters of our study (0.26 μg/l) as
show in Figure 8 and more than 23-fold when we com-
pared with the modified B. megaterium (8.52 μg/l) from
other studies [12,16].
Conclusions
In this study, we directed our attention to increase the
microbial biosynthesis of vitamin B12 by developing the
fermentation process of B. megaterium. Two optimization
steps were used to increase yield of vitamin B12 from wild
type of B. megaterium. In the first step, the significance of
CoCl2, ALA and DMB as supplements was investigated to
increase the production of vitamin B12. In addition, we di-
vided the fermentation process into three stages. At thent growth times in third stage of fermentation with
with R2 = 94.11%, R2 (adjusted for df) =86.54%, Std. Dev = 1.26 and
Figure 6 Total vitamin B12 content from the second step of
optimization under different growth times in third stage of
fermentation with B. megaterium. All vitamin B12 measurements
were analyzed by ANOVA analysis with R2 = 97.67%, R2 (adjusted
for df) = 94.68%, Std. Dev = 11.21 and Adeq Precision = 22.403.
Figure 7 Vitamin B12 content/g DCW from the second step of optimiza
with B. megaterium. All vitamin B12 measurements were analyzed by ANO
Dev = 20.724, mean absolute error = 5.48 and Adeq Precision =17.175.
Mohammed et al. Microbial Cell Factories 2014, 13:102 Page 7 of 10
http://www.microbialcellfactories.com/content/13/1/102first stage, the bacteria was grown aerobically to increase
the biomass, followed by anaerobic growth stage for pro-
duction of vitamin B12 precursor and in the third stage,
whole culture aeration step was used to complete vitamin
B12 formation. Using this optimization strategy, the
vitamin B12 yield was enhanced up to 44.38 μg/l that is
an increase of more than 170-fold as compared with-
out the parameter studies (0.26 μg/l). In the second
strategy step, the incubation times for each stage of the
three stages of fermentation were investigated and opti-
mized using Box-Behnken design combined with Response
Surface Methodology (RSM) which led to increase vitamin
B12 up to 759-fold as compared with control.
From our study, we deduced the three main points to
improve the production of vitamin B12 by B. megaterium.
Firstly, the synthesis of uroporphyrinogen III which de-
rived from δ-aminolevulinic acid (ALA) could enhance
ALA by some genes such as hemA and hemL or through
the addition of ALA directly into the medium culture.
Secondly, providing anaerobic conditions for the culture
medium can enhance the synthesis of cobinamide through
the oxygen-independent pathway. Thirdly, the final step
of the biosynthesis of vitamin B12 includes the conversion
of cobinamide to vitamin B12 through the replacement
of the GDP group of adenosyl-GDP-cobinamide with
α-ribazole-p which consists of DMB attached to ribose.
In our studies, we stimulated B. megaterium to complete
the synthesis of vitamin B12 by adding exogenous DMBtion under different growth times in third stage of fermentation
VA analysis with R2 = 97.06%, R2 (adjusted for df) = 93.29%, Std.
Figure 8 Total vitamin B12 content in B. megaterium during whole optimization studies.
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phase fermentation because of that bioconversion was
obviously required molecular oxygen to be completed.
Further studies are underway to investigate these three
points in terms of metabolic engineering through the
overexpression of hemA and hemL genes form Rhodobacter
sphaeroides 2.4.1 to increase ALA yield in addition to
stimulate uroporphyrinogen III to flow towards cobalamin
pathway instead of the hemE branched pathway by
cloning cobA gene from P. freudenreichii CICC 10019.
Finally, this study demonstrates that B. megaterium




Cyanocobalamin, adenosylcobalamin and other chemicals
were purchased from Sigma. All other chemicals were of
reagent grade.
Microorganisms and media
Bacillus megaterium DSM319 wild-type strain was ob-
tained from DSMZ (German Collection of Microorgan-
isms and Cell Cultures, Braunschweig) and precultured
in sterile Luria–Bertani (LB) medium which consisted of
10 g peptone, 5 g yeast extract, and 10 g NaCl. Modified
TB medium was used for the fermentation and consisted
of per liter, 30 g glucose, 5 g glycerol, 24 g yeast extract,
and 12 g tryptone, 3 g MgSO4 · 7H2O, 3 g CaCO3, with
17 mM KH2PO4 and 72 mM K2HPO4. CoCl2 · 6H2O
(100 mg/l), ALA (100 mg/l) and DMB (100 mg/l) at
pH 6.8.Inoculum preparation and fermentation
After 2 ml culture was inoculated into 250 ml conical
flask containing 25 ml of LB medium and incubated for
16 h at 37s with a speed of 200 rpm, 10 ml were trans-
ferred to the fermentation culture. The fermentation
processes were carried out in batch mode during three
stages. In the first stage, the bacteria were grown aerob-
ically, followed by the anaerobic second stage, and the
third stage was subjected to aerobic growth to complete
the formation of vitamin B12. Aerobic cultivations were
grown in 500 ml shake flasks containing 100 ml of
modified TB at 200 rpm and 37°C. Anaerobic conditions
were achieved by incubating in an anaerobic incubator
at 37°C. For the optimization studies, the addition of
ALA, DMB and the time for each stage of the three
stages of the fermentation process was dependent on the
experimental design (Table 1).
Preparation of cell extracts
In order to analyze the yield of vitamin B12 obtained
from B. megaterium, the bacterial cells were harvested
by centrifugation (6,000 × g, 10 min, 4°C), washed twice
with deionized water. The bacterial cell pellet was resus-
pended into 1 g/1 ml lysozyme buffer, incubated at 37°C
for 30 min and followed by ultrasonic cell disruption
(Sonics & Materials, Inc. 53 Church Hill Road, Newtown,
CT 06470–1614 USA) for five times at 1-min interval
under ice . The cell extraction was made up to a final vol-
ume of 20 ml with sodium nitrite and potassium cyanide
(0.5: 0.2 g/100 ml) and then autoclaved at 120°C for
15 min. The mixture was centrifuged (8,000 × g; 10 min),
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extraction (SPE) column (500 mg C18 end-capped column
with a 3-ml reservoir volume) previously activated with
2 ml of acetonitrile. The column was washed twice with
distilled water to remove salts and other hydrophilic con-
taminants. Subsequently, the sample was eluted with 1 vol-
ume of 50% acetonitrile and concentrated to dry in
vacuum at 30°C. The residue was dissolved in 0.5 ml of
sterile distilled water and stored in the dark at 20°C until
further use.
Design of experiments
A two-step optimization strategy was employed to optimize
vitamin B12 production by B.megaterium.
The first step of optimization
In this step, the fermentation process was modified to
consist of three stages. Moreover, the addition of CoCl2,
ALA and DMB as supplements were studied and
compared with the control bacteria without parameters
according to the previous studies. Finally, the variables
were investigated in order to identify which variables
have significant effects on vitamin B12 biosynthesis.
Four variables (CoCl2, ALA, DMB and the division of
the fermentation process into three stages) were chosen
as factors. The total concentrations of vitamin B12 after
the whole fermentation were used as response in this
design.
The second step of optimization
In this step, a combination of RSM and Box–Behnken
design optimizes the time of the three stages of fermen-
tation which selected as the most significant variable by
the last strategy step. The software package Design-
Expert 8.0.6 (Stat Ease, Inc.,Minneapolis, USA) was used
in this study. The factors were used at three different
levels (−1, 0, + 1) with minimum, central and maximum
values. The minimum and maximum levels of each inde-
pendent variable and the experimental design are shown
in Table 1.
The treatment schedule for the model is given in Table 1.
Five replicates (run) at the center of the design were used
to estimate the pure error and sum of squares. Seventeen
experiments were randomly run as shown in Table 1. The
responses obtained from the experimental design were bio-
mass and the total vitamin B12 concentration (cyanocobala-
min and adenosylcobalamin). In addition, the amount of
vitamin B12 was obtained from 1 g of dry cells as the third
response.
Vitamin B12 analysis using HPLC
The corrinoids were purified from B. megaterium cell-
extracts and analyzed using Dionex Ultimate 3000(Thermo Scientific, Waltham, MA, USA) that comprised
of an auto sampler, and an Ultimate 3000 Variable Wave-
length detector (UV) set at 361 nm. Vitamin B12 concen-
tration was analyzed at a flow rate of 0.7 ml/min. The
system was completed with an Amethyst column type
Acclaim C18-H (5 μm, 4.6 × 250 mm). The compositions
of two mobile phases (A, B) were methanol: distilled
water (60:40) and (10:90) respectively with added
0.07 mL phosphoric acid. The samples and standards
were dissolved in the mobile phase and 10 μl sample vol-
ume was injected into the column at 30°C.
Identification of Vitamin B12 by mass spectrometry
Mass spectrometric analysis of B. megaterium cell ex-
traction was performed by the liquid chromatography/
mass spectrometry–ion trap–time of flight (LC-MS-IT-
TOF) (Shimadzu, Kyoto, Japan). Analysis parameters: Elec-
trospray ion source; Interface voltage of −3.50 kV, Nebulizer
gas flow of 1.5 L min − 1, CDL temperature of 200°C, Block
heater temperature of 200°C, Detector voltage of 1.60 kV,
Drying gas of 100 kpa, Ion accumulation time of 10 msec,
MS range of m/z 300 to 1500, CID parameters as energy
of 50%, collision gas of 100%, repeated of 10. MS data
were processed with LCMS solution ver. 3.4 software
(Shimadzu). Ten μl of the sample solution was intro-
duced into the ESI ion source of mass spectrometer via
the auto sampler of HPLC system with C18 column
(150 × 2.0 mm; Shimadzu, Kyoto, Japan).
Cell dry weight
Dry weight of biomass was estimated after centrifugation
and drying to constant weight at 103-105°C using a vacuum
oven.
Statistical analysis
The single factor experiments were analyzed using calcu-
lated means and standard deviations by using the software
Origin 8.5.1.
Analysis of variance (ANOVA) was carried out by using
the software package Design-Expert 8.0.6 (Stat Ease, Inc.,
Minneapolis, USA) and the significance of the difference
between means was determined by Duncan’s Multiple
Range test (P < 0.05). Values expressed are means ± standard
deviation.
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